In a major cause of concern over the safety and efficacy of the COVID-19 vaccine that has been granted emergency use authorisation by the authorities, an Alaskan healthcare worker who was administered Pfizer and BioNTech’s COVID-19 vaccine suffered a serious allergic reaction. The affected person is stable now after availing treatment for the allergic reaction.
The adverse reaction in the person was noticed minutes after they took the vaccine shots. This also came days after two other similar cases were reported earlier in the UK.
The adverse reaction in two cases in Britain forced the authorities in the country to issue a warning, saying that people with a history of anaphylaxis, or severe allergic reactions to medicine or food, should not take the Pfizer-BioNTech COVID-19 vaccine shots.
No history of allergies
Notably, the Alaskan health worker did not have any history of allergic reactions, reports suggest. The patient’s symptoms were resolved after they were given allergy treatment epinephrine. The patient is currently under a close watch.
The biggest vaccination drive in American history got underway on Monday with a critical care nurse here becoming the first person in the US to be vaccinated for COVID-19.
Meanwhile, few days ago, four volunteers who were given the Pfizer vaccine shots during the trial stage developed Bell’s Palsy later. Notably, Bell’s palsy is a medical condition that causes one half of the face to droop.
US FDA approved vaccine
US regulator, the Food and Drug Administration (FDA), had recently cleared the Pfizer and BioNTech vaccine for emergency use after the agency’s chief was threatened to clear it or tender his resignation by the Trump administration. Notably, US President Donald Trump has been vocal about the slow process in the FDA and criticised the agency for moving at a turtle’s speed.
The US FDA is also set to approve the COVID-19 vaccine developed by Moderna. The approval is likely to come this week.
To read the latest news in Gujarati click here